‘Spoiled insulin’: Sudan war disrupts drug supplies, fuelling smuggling
On a modest bed inside his war-battered home in the Khartoum North neighbourhood of the Sudanese capital, Khartoum, Murtada Mohieddin, a diabetic patient in his early 50s, carefully counts his remain…
On a modest bed inside his war-battered home in the Khartoum North neighbourhood of the Sudanese capital, Khartoum, Murtada Mohieddin, a diabetic pati
Read Full Story at Al Jazeera →Why This Matters
The collapse of Sudan’s insulin supply chain isn’t just a humanitarian crisis—it’s a warning of how war weaponizes chronic disease against civilians. With diabetes care now dependent on black markets and cross-border smuggling, the war’s economic fallout risks creating an entire generation of patients whose lives hang by the thread of corrupt middlemen rather than medical infrastructure.
Background Context
Sudan’s pre-war healthcare system relied heavily on imported medicines, but the conflict has severed supply chains while simultaneously inflating prices beyond reach. The Khartoum North neighborhood, once a hub for affordable generics, now mirrors the broader fragmentation of a country where state institutions have collapsed into warlord-controlled fiefdoms.
What Happens Next
If the fighting persists, insulin shortages will likely push more patients toward unregulated alternatives, from bootleg vials to traditional remedies, with devastating long-term consequences. International aid agencies face a Catch-22: either risk fueling smuggling networks by delivering supplies or watch the crisis metastasize into a public health catastrophe.
Bigger Picture
This isn’t an isolated failure but a microcosm of how modern wars—from Syria to Yemen—systematically dismantle healthcare for the most vulnerable. As supply chains become collateral damage, the burden of survival shifts from systems to individuals, normalizing the erosion of basic rights in the name of survival.
